FDA inspection
Galephar Pharmaceutical Research, Inc.: FDA inspection ending Aug 31, 2016
FDA inspection 983512 · No Action Indicated (NAI) · Humacao, PR
Key facts
| Inspection ID | 983512 |
|---|---|
| Firm | Galephar Pharmaceutical Research, Inc. |
| FEI number | 3008206797 |
| Address | Rd 3 R925 Bo Junquitos Int, Punta Santiago, PR 00741 |
| City | Humacao |
| State | PR |
| ZIP | 741 |
| Fiscal year | 2016 |
| Inspection end date | Aug 31, 2016 |
| Classification | No Action Indicated (NAI) |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data